Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
212
Views
7
CrossRef citations to date
0
Altmetric
Review

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment

Laura R Steeples1 Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK;2 Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UKCorrespondence[email protected]
,
Sasa Pockar1 Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
,
Nicholas P Jones1 Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK;2 Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK
&
Inês Leal3 Ophthalmology Department, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal;4 Centro de Estudos das Ciências da Visão, Faculdade de Medicina, Universidade de Lisboa, Lisbon, PortugalORCID Iconhttps://orcid.org/0000-0001-9622-8779
ORCID Icon
Pages 1433-1442 | Published online: 07 Apr 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lara Buhl, Valerie Schmelter, Benedikt Schworm, Stephan Thurau & Christoph Kern. (2023) Long-Term Results of 0.19mg Fluocinolone Acetonide Insert for Treatment of Non-Infectious Uveitis in Clinical Practice. Ocular Immunology and Inflammation 0:0, pages 1-5.
Read now

Articles from other publishers (6)

Lara Buhl, Stephan Thurau & Christoph Kern. (2022) Fluocinolone acetonide 0.19-mg implant for the treatment of noninfectious uveitis with involvement of the posterior segment: a real-world study. Graefe's Archive for Clinical and Experimental Ophthalmology 261:4, pages 1101-1108.
Crossref
Peter Chang. (2022) Use of fluocinolone acetonide intravitreal implant to manage chronic panuveitis for long-term inflammatory control without interfering with systemic immunity. Digital Journal of Ophthalmology 28:4, pages 119-125.
Crossref
Anne Studsgaard, Kåre Ørts Clemmensen & Mette Slot Nielsen. (2021) Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients. Graefe's Archive for Clinical and Experimental Ophthalmology 260:5, pages 1633-1639.
Crossref
Marco Battista, Vincenzo Starace, Maria Vittoria Cicinelli, Luigi Capone, Alessandro Marchese, Giulio Modorati, Francesco Bandello & Elisabetta Miserocchi. (2021) Efficacy of 0.19 mg Fluocinolone Acetonide Implant in Non-infectious Posterior Uveitis Evaluated as Area Under the Curve. Ophthalmology and Therapy 11:1, pages 215-224.
Crossref
Madhuri Dandamudi, Peter McLoughlin, Gautam Behl, Sweta Rani, Lee Coffey, Anuj Chauhan, David Kent & Laurence Fitzhenry. (2021) Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery. Pharmaceutics 13:10, pages 1590.
Crossref
Christopher D. Conrady & Steven Yeh. (2021) A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future. Pharmaceutics 13:8, pages 1224.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.